{
  "nctId": "NCT03098563",
  "briefTitle": "Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis",
  "officialTitle": "Maximizing Analgesia to Reduce Pain Sensitivity in Chronic Knee Osteoarthritis Pain Patients",
  "protocolDocument": {
    "nctId": "NCT03098563",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-08-17",
    "uploadDate": "2024-11-12T14:55",
    "size": 286231,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03098563/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "CROSSOVER",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 58,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-11-01",
    "completionDate": "2023-11-27",
    "primaryCompletionDate": "2023-11-17",
    "firstSubmitDate": "2017-03-17",
    "firstPostDate": "2017-04-04"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Diagnosis of knee osteoarthritis\n* Urine sample tests negative for common illicit substances of abuse (e.g., cannabis)\n* Medically cleared to take study medications\n* Are not pregnant or breast feeding\n* Willing to comply with the study protocol.\n\nExclusion Criteria:\n\n* Pain other than Knee Osteoarthritis\n* Taking opioids for pain\n* Prescribed and taking gabapentinoid, Tricyclic Antidepressants (TCA), venlafaxine, duloxetine, stimulants or benzodiazepines\n* Presence of any clinically significant medical/psychiatric illness judged by the investigators to put subject at elevated risk for experiencing an adverse event\n* Known allergy to the blinded study medications",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "45 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Largest Change From Baseline on Clinical Pain Rating",
        "description": "The study will measure whether blinded study medications change clinical pain ratings (0-100 pain rating scale). Higher score indicates worse outcome. Biggest difference from baseline over the entire session is reported.",
        "timeFrame": "8 hour study session"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "PHASE2"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "CROSSOVER"
    },
    "overallComplexityScore": 39,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:57.579Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}